Skip to main content
PMC home page
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 1999 Nov;53(11):702–709. doi: 10.1136/jech.53.11.702

Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group

M Porta, N Malats, L Guarner, A Carrato, J Rifa, A Salas, J M Corominas, M Andreu, F X Real
PMCID: PMC1756794  PMID: 10656099

Abstract

STUDY OBJECTIVE: To analyse the relation between coffee consumption and mutations in the K-ras gene in exocrine pancreatic cancer. DESIGN: Case- case study. Consumption of coffee among cases with the activating mutation in the K-ras gene was compared with that of cases without the mutation. SETTING AND PATIENTS: All cases of pancreatic cancer newly diagnosed at five hospitals in Spain during three years were included in the PANKRAS II Study (n = 185, of whom 121 whose tissue was available for molecular analysis are the object of the present report). Over 88% were personally interviewed in hospital. DNA was amplified from paraffin wax embedded tissues, and mutations in codon 12 of K-ras were detected by the artificial RFLP technique. MAIN RESULTS: Mutations were found in tumours from 94 of 121 patients (77.7%). Mutations were more common among regular coffee drinkers than among non-regular coffee drinkers (82.0% v 55.6%, p = 0.018, n = 107). The odds ratio adjusted by age, sex, smoking and alcohol drinking was 5.41 (95% CI 1.64, 17.78). The weekly intake of coffee was significantly higher among patients with a mutated tumour (mean of 14.5 cups/week v 8.8 among patients with a wild type tumour, p < 0.05). With respect to non- regular coffee drinkers, the odds ratio of a mutated tumour adjusted by age, sex, smoking and alcohol drinking was 3.26 for drinkers of 2-7 cups/week, 5.77 for drinkers of 8-14 cups/week and 9.99 for drinkers of > or = 15 cups/week (p < 0.01, test for trend). CONCLUSIONS: Pancreatic cancer cases without activating mutations in the K-ras gene had drank significantly less coffee than cases with a mutation, with a significant dose response relation: the less they drank, the less likely their tumours were to harbour a mutation. In exocrine pancreatic cancer the K-ras gene may be activated less often among non-regular coffee drinkers than among regular drinkers. Caffeine, other coffee compounds or other factors with which coffee drinking is associated may modulate K-ras activation.

 

Full Text

The Full Text of this article is available as a PDF (123.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agapova L. S., Ilyinskaya G. V., Turovets N. A., Ivanov A. V., Chumakov P. M., Kopnin B. P. Chromosome changes caused by alterations of p53 expression. Mutat Res. 1996 Jul 5;354(1):129–138. doi: 10.1016/0027-5107(96)00062-0. [DOI] [PubMed] [Google Scholar]
  2. Begg C. B., Zhang Z. F. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev. 1994 Mar;3(2):173–175. [PubMed] [Google Scholar]
  3. Berrozpe G., Schaeffer J., Peinado M. A., Real F. X., Perucho M. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int J Cancer. 1994 Jul 15;58(2):185–191. doi: 10.1002/ijc.2910580207. [DOI] [PubMed] [Google Scholar]
  4. Bolúmar F., Olsen J., Rebagliato M., Bisanti L. Caffeine intake and delayed conception: a European multicenter study on infertility and subfecundity. European Study Group on Infertility Subfecundity. Am J Epidemiol. 1997 Feb 15;145(4):324–334. doi: 10.1093/oxfordjournals.aje.a009109. [DOI] [PubMed] [Google Scholar]
  5. Caldas C., Kern S. E. K-ras mutation and pancreatic adenocarcinoma. Int J Pancreatol. 1995 Aug;18(1):1–6. doi: 10.1007/BF02825415. [DOI] [PubMed] [Google Scholar]
  6. Colston K. W., James S. Y., Ofori-Kuragu E. A., Binderup L., Grant A. G. Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro. Br J Cancer. 1997;76(8):1017–1020. doi: 10.1038/bjc.1997.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. D' Avanzo B., La Vecchia C., Katsouyanni K., Negri E., Trichopoulos D. Reliability of information on cigarette smoking and beverage consumption provided by hospital controls. Epidemiology. 1996 May;7(3):312–315. doi: 10.1097/00001648-199605000-00018. [DOI] [PubMed] [Google Scholar]
  8. DeFrank J. S., Tang W., Powell S. N. p53-null cells are more sensitive to ultraviolet light only in the presence of caffeine. Cancer Res. 1996 Dec 1;56(23):5365–5368. [PubMed] [Google Scholar]
  9. Efferth T., Fabry U., Glatte P., Osieka R. Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells. J Cancer Res Clin Oncol. 1995;121(11):648–656. doi: 10.1007/BF01218522. [DOI] [PubMed] [Google Scholar]
  10. Escolar Pujolar A., González C. A., López-Abente G., Errezola M., Izarzugaza I., Nebot M., Riboli E. Bladder cancer and coffee consumption in smokers and non-smokers in Spain. Int J Epidemiol. 1993 Feb;22(1):38–44. doi: 10.1093/ije/22.1.38. [DOI] [PubMed] [Google Scholar]
  11. Falk R. T., Pickle L. W., Fontham E. T., Correa P., Fraumeni J. F., Jr Life-style risk factors for pancreatic cancer in Louisiana: a case-control study. Am J Epidemiol. 1988 Aug;128(2):324–336. doi: 10.1093/oxfordjournals.aje.a114972. [DOI] [PubMed] [Google Scholar]
  12. Gavaldà L., Porta M., Malats N., Piñol J. L., Fernández E., Maguire A., Cortès I., Carrillo E., Marrugat M., Rifà J. Concordancia entre la información facilitada por el paciente y un familiar sobre antecedentes patológicos, consumo de tabaco, de alcohol, de café, y dieta en el cáncer de páncreas exocrino y del sistema biliar extrahepático. Gac Sanit. 1995 Nov-Dec;9(51):334–342. doi: 10.1016/s0213-9111(95)71258-4. [DOI] [PubMed] [Google Scholar]
  13. Gold E. B. Epidemiology of and risk factors for pancreatic cancer. Surg Clin North Am. 1995 Oct;75(5):819–843. doi: 10.1016/s0039-6109(16)46730-7. [DOI] [PubMed] [Google Scholar]
  14. Gordis L. Consumption of methylxanthine-containing beverages and risk of pancreatic cancer. Cancer Lett. 1990 Jun 30;52(1):1–12. doi: 10.1016/0304-3835(90)90070-e. [DOI] [PubMed] [Google Scholar]
  15. Gullo L., Pezzilli R., Morselli-Labate A. M., Italian Pancreatic Cancer Study Group Coffee and cancer of the pancreas: an Italian multicenter study. Pancreas. 1995 Oct;11(3):223–229. doi: 10.1097/00006676-199510000-00002. [DOI] [PubMed] [Google Scholar]
  16. Harnack L. J., Anderson K. E., Zheng W., Folsom A. R., Sellers T. A., Kushi L. H. Smoking, alcohol, coffee, and tea intake and incidence of cancer of the exocrine pancreas: the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev. 1997 Dec;6(12):1081–1086. [PubMed] [Google Scholar]
  17. Howe G. R., Burch J. D. Nutrition and pancreatic cancer. Cancer Causes Control. 1996 Jan;7(1):69–82. doi: 10.1007/BF00115639. [DOI] [PubMed] [Google Scholar]
  18. James J. E., Bruce M. S., Lader M. H., Scott N. R. Self-report reliability and symptomatology of habitual caffeine consumption. Br J Clin Pharmacol. 1989 Apr;27(4):507–514. doi: 10.1111/j.1365-2125.1989.tb05400.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kennedy J. S., von Moltke L. L., Harmatz J. S., Engelhardt N., Greenblatt D. J. Validity of self-reports of caffeine use. J Clin Pharmacol. 1991 Jul;31(7):677–680. doi: 10.1002/j.1552-4604.1991.tb03756.x. [DOI] [PubMed] [Google Scholar]
  20. Link C. J., Jr, Evans M. K., Cook J. A., Muldoon R., Stevnsner T., Bohr V. A. Caffeine inhibits gene-specific repair of UV-induced DNA damage in hamster cells and in human xeroderma pigmentosum group C cells. Carcinogenesis. 1995 May;16(5):1149–1155. doi: 10.1093/carcin/16.5.1149. [DOI] [PubMed] [Google Scholar]
  21. Lyon J. L., Mahoney A. W., French T. K., Moser R., Jr Coffee consumption and the risk of cancer of the exocrine pancreas: a case-control study in a low-risk population. Epidemiology. 1992 Mar;3(2):164–170. doi: 10.1097/00001648-199203000-00015. [DOI] [PubMed] [Google Scholar]
  22. López-Abente G., González C. A., Errezola M., Escolar A., Izarzugaza I., Nebot M., Riboli E. Tobacco smoke inhalation pattern, tobacco type, and bladder cancer in Spain. Am J Epidemiol. 1991 Oct 15;134(8):830–839. doi: 10.1093/oxfordjournals.aje.a116158. [DOI] [PubMed] [Google Scholar]
  23. Maclure M., Greenland S. Tests for trend and dose response: misinterpretations and alternatives. Am J Epidemiol. 1992 Jan 1;135(1):96–104. doi: 10.1093/oxfordjournals.aje.a116206. [DOI] [PubMed] [Google Scholar]
  24. Malats N., Porta M., Corominas J. M., Piñol J. L., Rifà J., Real F. X. Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption. PANK-ras I Project Investigators. Int J Cancer. 1997 Mar 17;70(6):661–667. doi: 10.1002/(sici)1097-0215(19970317)70:6<661::aid-ijc6>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  25. Malats N., Porta M., Fernandez E., Real F. X. Re: Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. J Natl Cancer Inst. 1994 Sep 7;86(17):1353–1355. doi: 10.1093/jnci/86.17.1353-a. [DOI] [PubMed] [Google Scholar]
  26. Malats N., Porta M., Piñol J. L., Corominas J. M., Rifà J., Real F. X. Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. PANK-ras I Project Investigators. J Clin Oncol. 1995 Jul;13(7):1679–1686. doi: 10.1200/JCO.1995.13.7.1679. [DOI] [PubMed] [Google Scholar]
  27. Malats N., Real F. X., Porta M. DDT and pancreatic cancer. J Natl Cancer Inst. 1993 Feb 17;85(4):328–329. doi: 10.1093/jnci/85.4.328. [DOI] [PubMed] [Google Scholar]
  28. Moskaluk C. A., Hruban R. H., Kern S. E. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res. 1997 Jun 1;57(11):2140–2143. [PubMed] [Google Scholar]
  29. Mulcahy H. E., Lyautey J., Lederrey C., qi Chen X., Anker P., Alstead E. M., Ballinger A., Farthing M. J., Stroun M. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin Cancer Res. 1998 Feb;4(2):271–275. [PubMed] [Google Scholar]
  30. Murnane J. P. Cell cycle regulation in response to DNA damage in mammalian cells: a historical perspective. Cancer Metastasis Rev. 1995 Mar;14(1):17–29. doi: 10.1007/BF00690208. [DOI] [PubMed] [Google Scholar]
  31. Müller W. U., Bauch T., Wojcik A., Böcker W., Streffer C. Comet assay studies indicate that caffeine-mediated increase in radiation risk of embryos is due to inhibition of DNA repair. Mutagenesis. 1996 Jan;11(1):57–60. doi: 10.1093/mutage/11.1.57. [DOI] [PubMed] [Google Scholar]
  32. Nishi M., Ohba S., Hirata K., Miyake H. Dose-response relationship between coffee and the risk of pancreas cancer. Jpn J Clin Oncol. 1996 Feb;26(1):42–48. doi: 10.1093/oxfordjournals.jjco.a023177. [DOI] [PubMed] [Google Scholar]
  33. Piegorsch W. W., Weinberg C. R., Taylor J. A. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med. 1994 Jan 30;13(2):153–162. doi: 10.1002/sim.4780130206. [DOI] [PubMed] [Google Scholar]
  34. Rothman N., Stewart W. F., Schulte P. A. Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories. Cancer Epidemiol Biomarkers Prev. 1995 Jun;4(4):301–311. [PubMed] [Google Scholar]
  35. Rozenblum E., Schutte M., Goggins M., Hahn S. A., Panzer S., Zahurak M., Goodman S. N., Sohn T. A., Hruban R. H., Yeo C. J. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res. 1997 May 1;57(9):1731–1734. [PubMed] [Google Scholar]
  36. Schreiber G. B., Maffeo C. E., Robins M., Masters M. N., Bond A. P. Measurement of coffee and caffeine intake: implications for epidemiologic research. Prev Med. 1988 May;17(3):280–294. doi: 10.1016/0091-7435(88)90004-7. [DOI] [PubMed] [Google Scholar]
  37. Schreiber G. B., Robins M., Maffeo C. E., Masters M. N., Bond A. P., Morganstein D. Confounders contributing to the reported associations of coffee or caffeine with disease. Prev Med. 1988 May;17(3):295–309. doi: 10.1016/0091-7435(88)90005-9. [DOI] [PubMed] [Google Scholar]
  38. Silverman D. T., Swanson C. A., Gridley G., Wacholder S., Greenberg R. S., Brown L. M., Hayes R. B., Swanson G. M., Schoenberg J. B., Pottern L. M. Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst. 1998 Nov 18;90(22):1710–1719. doi: 10.1093/jnci/90.22.1710. [DOI] [PubMed] [Google Scholar]
  39. Soler M., Porta M., Malats N., Guarner L., Costafreda S., Gubern J. M., García-Olivares E., Andreu M., Real F. X. Learning from case reports: diagnostic issues in an epidemiologic study of pancreatic cancer. J Clin Epidemiol. 1998 Dec;51(12):1215–1221. doi: 10.1016/s0895-4356(98)00130-9. [DOI] [PubMed] [Google Scholar]
  40. Tada M., Ohashi M., Shiratori Y., Okudaira T., Komatsu Y., Kawabe T., Yoshida H., Machinami R., Kishi K., Omata M. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology. 1996 Jan;110(1):227–231. doi: 10.1053/gast.1996.v110.pm8536861. [DOI] [PubMed] [Google Scholar]
  41. Taylor J. A. Oncogenes and their applications in epidemiologic studies. Am J Epidemiol. 1989 Jul;130(1):6–13. doi: 10.1093/oxfordjournals.aje.a115323. [DOI] [PubMed] [Google Scholar]
  42. Terhune P. G., Phifer D. M., Tosteson T. D., Longnecker D. S. K-ras mutation in focal proliferative lesions of human pancreas. Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):515–521. [PubMed] [Google Scholar]
  43. Vineis P., Malats N., Porta M., Real F. X. Human cancer, carcinogenic exposures and mutation spectra. Mutat Res. 1999 Mar;436(2):185–194. [PubMed] [Google Scholar]
  44. Vineis P., Porta M. Causal thinking, biomarkers, and mechanisms of carcinogenesis. J Clin Epidemiol. 1996 Sep;49(9):951–956. doi: 10.1016/0895-4356(96)00118-7. [DOI] [PubMed] [Google Scholar]
  45. Weiderpass E., Partanen T., Kaaks R., Vainio H., Porta M., Kauppinen T., Ojajärvi A., Boffetta P., Malats N. Occurrence, trends and environment etiology of pancreatic cancer. Scand J Work Environ Health. 1998 Jun;24(3):165–174. doi: 10.5271/sjweh.295. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES